Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Observational, Multi-Center, Single-Arm, Consecutive Enrollment, Post-Marketing, International Registry of the Surpass™ Flow Diverter in Intracranial Arteries

NCT02281721 is registered in ClinicalTrials.gov with Stryker Neurovascular as lead sponsor.

NCT NCT02281721
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02281721 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Observational, Multi-Center, Single-Arm, Consecutive Enrollment, Post-Marketing, International Registry of the Surpass™ Flow Diverter in Intracranial Arteries
Lead sponsor
Stryker Neurovascular
Phase
Observational
Overall status
Terminated
Start date
March 18, 2015
Completion date
December 31, 2019
Enrollment
150 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral aneurysm